Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 10.68%231.05M | 19.74%71.43M | -21.22%44.29M | -4.99%63.35M | 98.32%51.98M | 400.76%208.76M | 383.21%59.65M | 799.13%56.22M | 370.48%66.68M | 26.21M |
Net income from continuing operations | 46.99%190M | 8.41%54.51M | 36.35%55.25M | 44.68%47.41M | 477.65%32.83M | 6.34%129.26M | 181.92%50.28M | 32.42%40.52M | -13.55%32.77M | --5.68M |
Depreciation and amortization | 3.60%56.7M | -1.85%13.69M | 7.20%14.81M | 6.87%14.35M | 2.30%13.85M | 22.50%54.73M | 2.93%13.94M | 19.82%13.82M | 36.24%13.43M | --13.54M |
Deferred tax | -266.15%-10.84M | -83.66%-11.53M | -34.51%222K | -100.10%-3K | --475K | 49.66%-2.96M | -17.72%-6.28M | 6,680.00%339K | --2.98M | --0 |
Other non cash items | ---- | ---- | ---- | ---- | ---- | -16,956.67%-20.47M | ---7.07M | ---1M | ---- | ---- |
Change In working capital | -162.02%-19.92M | 169.06%10.28M | -3,678.48%-29.85M | -108.21%-2.23M | -1.31%1.88M | 125.10%32.12M | 123.55%3.82M | 98.50%-790K | 177.26%27.18M | --1.91M |
-Change in receivables | 54.59%-47.23M | 93.38%-2.93M | -39.26%-44.93M | -74.31%-39.83M | 965.70%40.45M | -314.57%-104.02M | -583.22%-44.23M | -101.45%-32.26M | -159.17%-22.85M | ---4.67M |
-Change in inventory | -160.78%-72.09M | -282.03%-44.13M | -365.72%-44.71M | -101.10%-490K | -75.00%17.24M | 188.65%118.61M | -192.49%-11.55M | 138.72%16.83M | 163.61%44.4M | --68.94M |
-Change in prepaid assets | -131.75%-4.87M | -101.90%-416K | -77.11%1.29M | 30.26%-8.12M | 502.20%2.38M | 237.43%15.32M | 658.92%21.92M | 4,632.77%5.63M | -79.21%-11.64M | ---591K |
-Change in payables and accrued expense | 502.05%55.59M | -78.71%8.67M | 8,089.45%59.84M | 99.69%50.32M | -13.05%-63.24M | 397.01%9.23M | 860.20%40.72M | 96.33%-749K | -9.48%25.2M | ---55.94M |
-Change in other current assets | 116.14%796K | 226.53%1.2M | 744.62%2.93M | -73.42%-2.42M | 56.90%-918K | -17,510.71%-4.93M | -413.51%-950K | -151.53%-455K | -211.68%-1.4M | ---2.13M |
-Change in other working capital | 2,389.57%47.88M | ---- | ---- | 73.95%-1.7M | 261.91%5.98M | 92.64%-2.09M | ---- | ---- | 75.45%-6.53M | ---3.69M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 10.68%231.05M | 19.74%71.43M | -21.22%44.29M | -4.99%63.35M | 98.32%51.98M | 400.76%208.76M | 383.21%59.65M | 799.13%56.22M | 370.48%66.68M | --26.21M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 10.43%-39.32M | 26.79%-8.08M | 11.50%-8.56M | 7.71%-11.94M | -4.72%-10.76M | 91.67%-43.9M | 97.81%-11.03M | -25.87%-9.67M | -46.07%-12.93M | -10.27M |
Net PPE purchase and sale | 10.34%-39.42M | 25.89%-8.18M | 11.50%-8.56M | 6.26%-11.94M | -2.07%-10.76M | -16.06%-43.97M | 21.78%-11.03M | -25.87%-9.67M | -43.82%-12.73M | ---10.54M |
Net business purchase and sale | 49.25%100K | --100K | --0 | --0 | --0 | 100.01%67K | --0 | --0 | ---200K | --267K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 10.43%-39.32M | 26.79%-8.08M | 11.50%-8.56M | 7.71%-11.94M | -4.72%-10.76M | 91.67%-43.9M | 97.81%-11.03M | -25.87%-9.67M | -46.07%-12.93M | ---10.27M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1.80%-170.98M | -16.30%-50.95M | 24.11%-38.11M | 25.41%-38.36M | -52.00%-43.57M | -136.85%-174.11M | -108.73%-43.8M | -6,845.23%-50.21M | -664.84%-51.43M | -28.66M |
Net issuance payments of debt | 40.65%-94.43M | -80.02%-54.05M | 78.36%-10.83M | 71.50%-14.83M | 45.51%-14.73M | -132.02%-159.1M | -105.92%-30.03M | ---50.03M | ---52.03M | ---27.03M |
Net common stock issuance | -414.42%-80.81M | 93.96%-888K | -15,394.44%-27.89M | -6,083.29%-24.42M | -6,276.21%-27.61M | 21.19%-15.71M | -6,674.65%-14.7M | 88.17%-180K | 94.69%-395K | ---433K |
Proceeds from stock option exercised by employees | 303.68%4.71M | --2.95M | 3,162.16%1.21M | 170.37%219K | -67.59%340K | 11.57%1.17M | --0 | -51.95%37K | -90.94%81K | --1.05M |
Net other financing activities | 2.78%-454K | 13.56%1.05M | -1,197.83%-597K | -26.56%669K | 30.21%-1.57M | 91.50%-467K | 119.10%922K | -106.37%-46K | 620.57%911K | ---2.25M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1.80%-170.98M | -16.30%-50.95M | 24.11%-38.11M | 25.41%-38.36M | -52.00%-43.57M | -136.85%-174.11M | -108.73%-43.8M | -6,845.23%-50.21M | -664.84%-51.43M | ---28.66M |
Net cash flow | ||||||||||
Beginning cash position | -20.03%36.81M | 41.23%45.13M | 33.09%47.47M | 3.38%34.43M | -20.03%36.81M | -21.69%46.03M | -9.83%31.95M | -31.37%35.67M | -37.66%33.31M | --46.03M |
Current changes in cash | 324.24%20.75M | 157.75%12.4M | 35.27%-2.37M | 463.60%13.05M | 81.59%-2.34M | 26.89%-9.25M | -54.59%4.81M | 77.76%-3.66M | 264.84%2.32M | ---12.72M |
Effect of exchange rate changes | -1,425.00%-424K | -902.04%-393K | 148.21%27K | -144.19%-19K | -875.00%-39K | 134.41%32K | 1,533.33%49K | 34.88%-56K | 176.79%43K | ---4K |
End cash Position | 55.20%57.14M | 55.20%57.14M | 41.23%45.13M | 33.09%47.47M | 3.38%34.43M | -20.03%36.81M | -20.03%36.81M | -9.83%31.95M | -31.37%35.67M | --33.31M |
Free cash flow | 16.28%191.63M | 30.10%63.25M | -23.24%35.74M | -4.69%51.41M | 163.03%41.23M | 4,230.88%164.79M | 2,863.84%48.62M | 396.13%46.56M | 914.18%53.94M | --15.67M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |